Dementia-care mapping (DCM) is an intervention for reducing neuropsychiatric symptoms in people with dementia in nursing homes. This article discusses a randomised controlled trial into the effectiveness of DCM and an investigation of the costs of DCM.
DCM appears to be cost-neutral as an intervention; additional costs are balanced by reduced outpatient hospital appointments. DCM has generally positive effects on resident outcomes such as depression, agitation and quality of life. Nursing homes’ preferences probably determine whether DCM is adopted.
van de Ven, G. Draskovic, I. [and] van Herpen, E. [et al] (2014). The economics of dementia-care mapping in nursing homes: a cluster-randomised controlled trial. PloS One, 2014, Vol.9(1), pp.e86662. (Click here to view the PubMed abstract).